Elevated expression of FGF9, FGF10, FGF18, FGF-23 and FGFR2IIIc was observed in CRC, and expression of FGF9 and FGFR2IIIc negatively correlated with patients’ survival[9, 12-16]. Here, FGF9 is linked to colorectal carcinoma.